Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Citurgia Biochemicals has informed that it enclosed revised Standalone unaudited Financial Results for the quarter ended on 30th June, 2023. Further, it has informed that in earlier submission dated 21st October, 2023, Limited Review Report issued by the statutory auditor for the quarter ended on 30th June, 2023 could not be submitted. Except above, there is no change in the results submitted to stock exchange dated 21st October, 2023.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| BASF India | 3693.20 |
| Tata Chemicals | 707.70 |
| SRF | 2474.05 |
| Pidilite Inds. | 1407.65 |
| Deepak Nitrite | 1645.15 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: